Skip to main content

3 Result(s)

within Marta Szydlowska Remove this filter

and

  1. No Access

    Article

    Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

    Non-alcoholic fatty liver disease ranges from steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma (HCC). Here, w...

    Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska… in Nature Medicine (2019)

  2. Article

    Open Access

    NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Hepatocellular carcinoma (HCC) can have viral or non-viral causes1–5. Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treating HCC, but biomarker-based stra...

    Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Olivier Govaere… in Nature (2021)

    Download PDF (88398 KB) View Article

  3. Article

    Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

    Mohsen Malehmir, Dominik Pfister, Suchira Gallage, Marta Szydlowska… in Nature Medicine (2022)

    Download PDF (591 KB) View Article